ArticleThe Journal of experimental medicine2015

Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells.

Dong Woo Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.